DRF-10945

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDRF-10945
Drug Alias NameDRF-10945
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsLipid Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDr.Reddy's Laboratories Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPerlecanDr.Reddy's Laboratories Ltd
Active IndicationsN/A
Inactive IndicationsLipid Metabolism Disorders

Other Information

ATC CodeN/A
Related LinksN/A